Study Objectives: It is unknown whether changes in sleep duration are associated with hypertension risk. The aim of this study was to investigate whether changes in sleep duration were associated with subsequent risk of developing hypertension in young and middle-aged women and men.
Introduction
Hypertension is a major contributor to cardiovascular disease and cardiovascular burden around the globe [1] . A large body of evidence suggests that preventing or delaying the onset of hypertension can be achieved by a healthy lifestyle that includes physical activity, a low-salt diet, and weight reduction [2, 3] . Despite advances in knowledge about the beneficial effects of therapeutic lifestyle changes on blood pressure (BP), it is challenging to implement a long-term lifestyle modification program at the population level because of low motivation and inadequate resources [4, 5] . Moreover, the effects of changing behaviors associated with weight reduction may be attenuated by sleep curtailment, a highly prevalent public concern in modern society [6] . In this context, sleep duration has received increasing attention as a cost-saving and potentially preventive measure.
Experimental evidence has shown that sleep restriction over 5-10 days increases BP and can elicit adverse effects on relevant hemodynamic and laboratory parameters [7] . Although epidemiological studies have attempted to link short sleep duration with increased risk of hypertension and some metaanalyses have identified such links, there is a gap between epidemiological and experimental evidence [8] . Sleep is a dynamic process and sleep patterns change over the course of an individual's life [9, 10] . However, most epidemiological studies in this field employed a single assessment of sleep at baseline, which limits the strength of any correlational relationships observed [11] . Thus, repeated assessment of sleep duration can enable us to investigate the association between changes in sleep duration and the subsequent risk for developing hypertension.
Therefore, we evaluated the association between change in sleep duration and risk of developing hypertension in healthy men and women.
Methods

Participants
The Kangbuk Samsung Health Study is an ongoing prospective cohort study of Korean adults who underwent comprehensive annual or biennial examinations at Kangbuk Samsung Hospital Screening Centers in Seoul and Suwon, South Korea. More than 80% of the participants were employees of various companies and local governmental organizations. Annual or biennial health screening exams are widely performed in Korea, as they are mandatory for all workers under Industrial Safety and Health Law. The remaining participants voluntarily paid for screening exams [12] . The study population consists of 125 699 Korean adults who completed self-administered questionnaires about habitual sleep duration and quality over the past month and other lifestyles with a comprehensive health checkup examination between March 2011 and December 2016. Eligible criteria for this study were a full set of data with at least three follow-up visits (visit one = baseline, visit two = exposure period, visit three = outcome measure). For our data analyses, we used changes in sleep duration at the first and the second visit for the main exposure of this study. Accordingly, we excluded participants during the exposure period when they reported a history of narcolepsy (n = 71), a history of cancer (n = 3513), a history of angina pectoris/myocardial infarction or coronary revascularization (n = 804), or a history of cerebrovascular disease (n = 434). We further excluded participants with hypertension (n = 14 398) during the exposure period. Because some individuals met more than one exclusion criterion, the total number of eligible participants for this study was n = 106 385. This study was approved by the Institutional Review Board of the Kangbuk Samsung Hospital, and informed consent was waived because researchers only retrospectively accessed a deidentified database for analysis purposes.
Exposure assessment
Sleep duration and sleep quality were measured using a selfadministered questionnaire with the Korean version of the Pittsburgh Sleep Quality Index (PSQI) at baseline and subsequent visits [13] . The PSQI consisted of 19 items that assessed seven components of habitual sleep during the past month: self-reported sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbance, use of sleeping medications, and daytime dysfunction. We used one item from the PSQI that asks about actual sleep duration at night in a typical 24-hour period over the past month to measure sleep duration. Sleep duration was rounded to the nearest hour. We calculated the change in sleep duration as the difference in habitual sleep duration between visit 1 and visit 2 (exposure period). Additionally, we categorized sleep duration at visit 1 and visit 2 into the following three categories: short (≤6 hours), moderate (7 hours), and long (≥8 hours). We created nine subgroups according to combinations of the three sleep duration categories.
Assessment of other variables
BP was measured using an automated oscillometric device (Model 53000; Welch Allyn, New York, NY) while participants were in a seated position with the arm supported at heart level. Three BP readings were recorded for each participant, and the average of the second and third readings was used in the analyses to reduce measurement error. Hypertension was defined as systolic BP ≥ 140 mmHg, diastolic BP ≥ 90 mmHg, or current use of antihypertensive medication. Demographic characteristics, employment status (not employed/employed), medical history, medication use, and lifestyle variables (smoking, alcohol consumption, and physical activity) were collected through standardized, self-administered questionnaires. Physical activity levels were assessed using the Korean-validated short version of the International Physical Activity Questionnaire (IPAQ) and was defined as weekly energy expenditure in metabolic equivalent (MET) hours/week. Body weight was measured to the nearest 0.1 kg using a digital scale with the patient wearing light clothing without shoes and height was measured by trained nurses. Body mass index (BMI) was calculated as weight/height squared (kg/m ; and obese, BMI ≥25 kg/m 2 ). Depression was assessed using the Korean version [14] of the Center for Epidemiologic Studies Depression (CES-D) Scale [15] . Blood samples were collected after at least a 10-hour fast. The methods for measuring serum levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol have been reported elsewhere [16] . Serum insulin was measured using an electrochemiluminescence immunoassay on a Modular Analytics E170 apparatus (Roche Diagnostics, Tokyo, Japan). Insulin resistance was assessed with the homeostasis model assessment of insulin resistance (HOMA-IR): fasting glucose (mg/dL) × fasting insulin (µIU/mL)/405.
Statistical analyses
The main exposure in this study was change in sleep duration and the study endpoint was development of hypertension. Follow-up for each participant extended from the end of the exposure period until the development of hypertension or until the last health exam that was conducted prior to December 31, 2016, whichever came first. A Cox proportional hazards model was used to compute hazard ratios (HRs) and 95% confidence intervals (95% CIs) for risk of incident hypertension, with no change in sleep duration being the reference group, and the assumption of proportional hazard was checked and accepted for all variables. We also evaluated risk within the subcategories using the combinations described earlier, with participants who received a constant duration of 7 hours of sleep being the reference group. We adjusted for sleep duration and the following covariates at the start of the exposure period: age, year of examination, study center, family history of hypertension, education, marital status, medical history of diabetes, employment status (yes/no), depressive symptom scores, antidepressant use, sleep apnea (ever-diagnosed), shiftwork, frequency of snoring, frequency of difficult breathing, use of sleeping pills, smoking status, alcohol consumption in quintiles, and physical activity (MET hours/week). Model 2 was then further adjusted for the following covariates at the end of the exposure period: concomitant sleep-quality change (good to good, good to poor, poor to good, or poor to poor), quintiles of changes in depressive symptoms scores, alcohol consumption, and MET hours/week. Last, BMI and weight change over time were further adjusted for in model 3. To evaluate the dose-response relationship, we also modeled the association between change in sleep duration and risk of incident hypertension using a restricted cubic spline model.
To reduce bias due to missing covariate data (missing rate = 1.3%−11.6%), we added missing indicators for categorical variables and replaced continuous missing variables with carried-forward values. For sensitivity analyses to test the robustness of our findings, we also conducted multiple-imputation chained equations (five times), excluded participants who worked night shifts, and we repeated our analysis using a new definition of hypertension (systolic BP ≥ 130 mmHg, diastolic BP ≥ 80 mmHg, or current use of antihypertensive medication). All p-values were two-tailed, and p-values <.05 were considered statistically significant. We used STATA version 14.0 (Stata Corp., College Station, TX) for all data analyses.
Results
Over the 1.3-year exposure period, 42.3% of women and 50.7% of men maintained a constant sleep duration. In both sexes, the percentage of consistently short sleepers was 38.2% and that of consistently long sleepers was 2.7%. A decrease of ≥1 hour of sleep was observed in 32% of the women and 27% of the men, while 25.7% of the women and 22.4% of the men reported an increase of ≥1 hour of sleep. Most participants who increased their sleep by ≥2 hours over the study period were sleep-deprived at the initial time point; approximately half of the respondents reported ≤5 hours of sleep. The mean age (and SD) of the participants was 40.6 (6.0) years at the start of the exposure period.
The baseline characteristics according to changes in sleep duration are presented in Table 1 . There was no difference in demographic profiles between the two time point measurements. The percentage of current smokers and participants reporting high alcohol consumption declined slightly while physical activity decreased slightly over the exposure period. Participants who did not experience changes in sleep duration were older, more likely to be university graduates, married, employed, current smokers, have a higher level of physical activity, and higher alcohol consumption, but were less likely to be shift workers and to have higher depressive symptom scores and poor self-reported sleep quality compared with those who changed their sleep duration over time.
Participants free of hypertension during the exposure period were followed up for a mean of 2.4 years. Over 250907.5 personyears of follow-up, 4750 incident cases of hypertension were identified; thus, the incidence rate was 18.9 per 1000 personyears. A decrease in sleep duration over time was associated with greater hypertension in women while an increase in sleep was associated with increased risk in men (Table 2 ). In analyses adjusting for age, study center, family history of hypertension, education level, marital status, history of diabetes, depressive symptoms, antidepressant use, history of sleep apnea, shiftwork, and use of sleeping pills at the beginning of the exposure period, adjusted HR (95% CI) for incident hypertension in women who decreased their sleep duration by ≥2 hours compared with those whose sleep duration did not change was 1.42 (1.06-1.91). This association remained significant and essentially unchanged after further adjustment for changes in these covariates and concomitant changes in self-reported sleep quality. Additional adjusting for BMI and weight changes only slightly attenuated this association (HR = 1.38; 95% CI = 1.01-1.87). In contrast, a considerable increase in sleep duration (≥2 hours) was associated with a higher risk of hypertension incidence in men, independently of relevant covariates, their changes, BMI, or weight change (HR = 1.37; 95% CI = 1.16-1.63). When evaluating the dose-response relationship with restricted cubic spline regression models, the risk of incident hypertension was lowest among participants with consistent sleep duration, but the relationship differed by sex. The risk significantly increased as sleep duration decreased by at least 1 hour in women, while the risk significantly increased as sleep duration increased by more than 1.5 hours in men (Figure 1 ).
Among subgroups of the different sleep-duration combinations (≤6 hours, 7 hours, and ≥8 hours) across visits one and two, women with persistently short sleep durations (≤6 hours) were at significantly greater risk of developing hypertension, independently of relevant confounders, changes in confounders, or adiposity (HR = 1.34; 95% CI = 1.05-1.70; Table 3 ). Risk did not differ between men with a consistent duration of 7 hours of sleep and men who were sleep-deprived at visit one but increased their sleep to 7 hours. However, men whose sleep duration changed from ≤6 hours to ≥8 hours were 32% more likely to develop hypertension in the subsequent 2.2 years (HR = 1.32; 95% CI = 1.01-1.73).
Sensitivity analyses
Our results were consistent and robust across several sensitivity analyses: compared with no changes in sleep, HRs for incident hypertension were 1.46 (HR = 1.8; 95% CI = 1.07-1.99) for women whose sleep decreased by ≥2 hours and 1.27 (HR = 1.8; 95% CI = 1.06-1.52) for men whose sleep increased by ≥2 hours when we excluded shift-worker participants, and 1.46 (HR = 1.8; 95% CI = 1.08-1.97) and 1.33 (HR = 1.8; 95% CI = 1.12-1.58) when we used multiple imputations for the missing variables within the exposure period. The association between change in sleep duration and subsequent risk of hypertension did not change materially after using the lower threshold (130/80 mmHg) for hypertension (Supplementary Tables S1 and S2 ).
Discussion
In this large study of healthy Korean adults without hypertension, a decrease in sleep duration over time was associated with subsequent risk of incident hypertension in women, independent of initial sleep duration, demographic factors, change in lifestyle behaviors, depressive symptoms, or weight. Women with persistently deprived sleep also had a higher risk of incident hypertension. In men, significantly increased sleep duration (≥2 hours) was at greater risk of developing hypertension, while there was no significant difference in risk of incident hypertension between patients who increased their sleep by 1 hour and the reference group. The large sample size of our study allowed for evaluating subsequent risk of incident hypertension associated with finely graded classifications of changes in sleep duration.
There is little epidemiological evidence that changes in sleep duration are associated with a subsequent risk of developing hypertension [17] . However, a few experimental studies support our findings. In a laboratory study of 18 Japanese workers, increases in pulse rate, sympathetic activity, and BP were observed after 3 hours of mean sleep duration compared with 8 hours of sleep. In another study of 13 healthy young volunteers (mean age 31 ± 2 years), vasodilation in response to acetylcholine and parasympathetic activity, assessed by heart-rate variability, was significantly lower in participants experiencing partial sleep deprivation (4.5 ± 0.3 hours) than in those who had regular sleep (8 ± 0.3 hours) [18] . Consistent with multiple previous studies, we also found that persistently short sleep duration was related to an elevated risk of hypertension in women.
Less is known about the association between increases in sleep duration and hypertension. One recent prospective study among British participants found that an increase in sleep duration over time was associated with an increased risk of stroke, a major complication of hypertension [19] . There are few data that address the cardiovascular effects of extended sleep duration.
One laboratory study showed that extending one's time in bed by 3 hours led to elevations in interleukin-6, a biomarker of systemic inflammation [20] . Consistent with those findings, we found that participants whose sleep duration increased by ≥2 hours were at an increased risk of developing hypertension. It is noteworthy that these participants were initially sleep-deprived (mean sleep duration of women and men at visit 1: 5.5 hours and 5.3 hours, respectively) and then became moderate sleepers. These findings suggest that a substantial increase in sleep duration is associated with future BP elevation. A considerable increase in sleep duration may be attributable to poor health conditions related to hypertension. However, the association remained significant after adjusting for our panel of indicators The HRs with 95% CIs were estimated using a cox proportional-hazards model. Multivariable model 1 was adjusted for age, year of screening examination, study center, family history of hypertension, education, marital status, medical history of diabetes, employment status(yes/no), depressive symptom scores, antidepressant use, sleep duration, sleep apnea (ever-diagnosed), shiftwork, frequency of snoring, frequency of difficult breathing, use of sleeping pills, smoking status, alcohol consumption in quintiles, and physical activity (MET hours/week) at visit 1; model 2: model 1 plus adjustment for concomitant sleep-quality change (good to good, good to poor, poor to good, or poor to poor), quintiles of changes in depressive symptoms scores, alcohol consumption, and MET hours/week from visit 1 to visit 2; model 3: model 2 plus adjustment for initial BMI and weight change from visit 1 to visit 2. Figure 1 . Multivariable-adjusted hazard ratios (solid line) and 95% confidence intervals (dashed lines) for incident hypertension by change in sleep duration, which was modeled using restricted cubic splines with knots at the 25th, 50th, and 75th percentiles. The reference was set at no change in sleep duration. The models were adjusted for age, year of examination, study center, family history of hypertension, education, marital status, medical history of diabetes, employment status (yes/ no), depressive symptom scores, antidepressant use, sleep duration, sleep apnea, shiftwork, frequency of snoring, frequency of difficult breathing, use of sleeping pills, smoking status, alcohol consumption in quintiles, physical activity (MET hour/week), concomitant sleep-quality change (good to good, good to poor, poor to good, or poor to poor), quintiles of changes in depressive symptom scores, alcohol consumption, MET hour/week, initial BMI, and weight change over time.
for these conditions, including depressive symptoms, employment level, physical activity, and changes in these variables. There are several plausible explanations for our observations. In earlier experimental studies, impaired autonomic function and adverse metabolic traits following voluntary sleep restriction by several hours for a short-term period emerged. Insufficient sleep is closely linked to weight gain through specific hormonal changes, including increased ghrelin and decreased leptin levels; adjusting for BMI and weight change partially attenuated the association between persistently short sleep, decrease in sleep duration, and risk of hypertension. A decrease in sleep duration and a concomitant increase in stress level can activate the hypothalamic-pituitary-adrenal system leading to excessive cortisol and this pathway appears to increase sympathetic nervous activity and insulin resistance. Recent evidence indicated that evening glucocorticoid excess can induce a nighttime non-dipping pattern in BP through impairing the NaCl cotransporter (NCC) [21] . In terms of a potential association between an increase in sleep duration and risk of hypertension, available evidence suggests that extended sleep duration can enhance inflammatory responses, contributing to pathogenesis of hypertension [22] . Multiple studies have concluded that homeostatic regulation of sleep duration interacts with a person's circadian rhythm [23, 24] . Given this potential synchronized interaction, a considerable increase in sleep may disturb the circadian rhythm underlying BP [25] . This may explain why participants who increased their sleep by 2 hours or more or those who substantially shifted from a short to long sleep duration experienced a significantly higher risk for incident hypertension.
Regarding the sex-difference in this association, our findings are consistent with previous literature. Several cross-sectional studies and two prospective studies reported that sleep-deprived women, but not men, were at a greater risk of developing hypertension [26] . Women appear to need a longer sleep duration than men, according to published normative data of sleep across the lifespan that shows that the average total sleep time is longer in women than men [27] . In this regard, women may be more vulnerable to cardiovascular consequences of sleep-deprived conditions. This gender-specific association was also corroborated by a laboratory study showing that, compared with men, women experienced higher psychological distress and metabolic disturbance following sleep restriction [28] . One animal study also suggested that NCC protein expression and activity are higher in females than in males [29] . The sex-specific mechanism explaining male predominance in hypertension incidence associated with increases in sleep duration is relatively less understood. Female hormones may protect against inflammation, accounting for the sex-difference [30] . A recent epidemiological study found that long sleep duration is associated with arterial stiffness, an important risk factor for hypertension in men. One recent report indicates that men are more affected by circadian typology, which can support our hypothesis that circadian disruption is driven by substantially increased sleep [31] .
Our study has several limitations. First, measurement of sleep duration was based on participants' self-reported sleep duration over the past month, which may lead to misclassification of exposure. Approximately half of the participants reported a change in sleep duration over the 1.3-year exposure period and future studies are needed to evaluate this association using objective and repeated sleep-duration measurements to capture the accurate change in sleep duration over time. Nevertheless, previous studies that compared self-reported data to objectively measured data in sleep measurement showed that there are moderately good correlations between them. Furthermore, cumulative data showed that self-reported sleep duration is associated with a number of cardiovascular health outcomes that can be objectively measured, indicating that self-reported sleep can be helpful for cardiovascular risk assessment, including hypertension. Second, causality cannot be inferred because our study is of an observational nature. Third, because we excluded participants who were free from hypertension at baseline and who met the criteria for hypertension at the end of the exposure period, potential survival bias leading to an underestimated association between change in sleep duration and incident hypertension might be introduced. Finally, standardized diagnostic measures were not used to screen obstructive sleep apnea, which may partly confound the association between long sleep duration and risk of incident hypertension. Alternatively, we adjusted for prior diagnosis of sleep apnea, BMI, poor self-reported sleep quality, snoring, and breathing, as reported in the questionnaire, to minimize potential confounding effects and found that this association remained statistically significant. The major strengths of our study include the large sample size allowing for finely graded classification of sleep duration and its changes. Along with the size of our dataset, our findings were strengthened by the complexity and variety of potential confounders and mediators that we obtained through highquality data measurement procedures. The use of relatively healthy participants consequently led to a study population that was less likely to be affected by comorbidities.
In summary, we found that decreases and increases in sleep duration over time compared with no change were associated with an increased risk of developing hypertension in women and men, respectively. Additionally, women with persistently short sleep had higher risk for incident hypertension, relative to those who maintained 7 hours of sleep. Our results underscore the significance of considerable changes in sleep duration over time as a contributor to hypertension development. Further work is encouraged to evaluate this association over long-term follow-up and to replicate the gender-specific association in other race/ethnicity groups.
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